Cargando…
Tumor Hypoxia as a Barrier in Cancer Therapy: Why Levels Matter
SIMPLE SUMMARY: Hypoxia is a common feature of solid tumors and associated with poor outcome in most cancer types and treatment modalities, including radiotherapy, chemotherapy, surgery and, most likely, immunotherapy. Emerging strategies, such as proton therapy and combination therapies with radiat...
Autores principales: | Hompland, Tord, Fjeldbo, Christina Sæten, Lyng, Heidi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7866096/ https://www.ncbi.nlm.nih.gov/pubmed/33525508 http://dx.doi.org/10.3390/cancers13030499 |
Ejemplares similares
-
A prognostic hypoxia gene signature with low heterogeneity within the dominant tumour lesion in prostate cancer patients
por: Salberg, Unn Beate, et al.
Publicado: (2022) -
Combining imaging- and gene-based hypoxia biomarkers in cervical cancer improves prediction of chemoradiotherapy failure independent of intratumour heterogeneity
por: Fjeldbo, Christina S., et al.
Publicado: (2020) -
miR‐200a/b/‐429 downregulation is a candidate biomarker of tumor radioresistance and independent of hypoxia in locally advanced cervical cancer
por: Nilsen, Anja, et al.
Publicado: (2022) -
Mitochondrial Function of CKS2 Oncoprotein Links Oxidative Phosphorylation with Cell Division in Chemoradioresistant Cervical Cancer()
por: Jonsson, Marte, et al.
Publicado: (2019) -
Identification and Validation of Reference Genes for RT-qPCR Studies of Hypoxia in Squamous Cervical Cancer Patients
por: Fjeldbo, Christina S., et al.
Publicado: (2016)